Patent · US Expired

Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases

US6307089A · kind A · utility

2Cited by
6References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 14, 2000
Grant dateOct 23, 2001
Priority date
Expiry dateDec 14, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C255/64
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Biphenyl butyric acid compounds and derivatives are described as well as acid methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix metalloproteinases, particularly gelatinase A (72 kD gelatinase) and stromelysin-1 and for the treatment of multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer, inflammation, pain, arthritis, or other autoimmune or inflammatory disorders dependent upon tissue invasion by leukocytes or other activated migrating cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.